Priothera Appoints Elisabeth Kueenburg M.D., as Chief Medical Officer

/PRNewswire/ -- Priothera Ltd, a late-clinical stage biotechnology company pioneering the development of its S1P receptor modulator compound, mocravimod,...

Related Keywords

Germany ,Frazer Hall ,Kilkenny ,Ireland ,Massachusetts ,United States ,Boston ,Sweden ,Austria ,Vienna ,Wien ,Dublin ,Berlin ,Florent Gros ,Elisabeth Kueenburg ,Sylvie Berrebi ,Sandi Greenwood ,Celgene Revlimid ,Priothera Ltd ,Tekla Capital Management ,University Of Vienna ,Clinical Development ,Chief Medical ,Acute Myeloid Leukemia ,Fountain Healthcare Partners ,Earlybird Venture Capital ,Priothera ,